A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Non-obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893

HRS-1893 tablet.

DRUG

HRS-1893 placebo

HRS-1893 tablet placebo.

Trial Locations (1)

RECRUITING

Fuwai Hospital, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY